Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84598386)
Watch
English
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review
scientific article published on 01 August 2011
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
main subject
chronic hepatitis B
1 reference
based on heuristic
inferred from title
chronic hepatitis
1 reference
based on heuristic
inferred from title
author name string
Yun-Fan Liaw
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
language of work or name
English
0 references
publication date
1 August 2011
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
volume
54
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
page(s)
E1-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
cites work
A "NEW" ANTIGEN IN LEUKEMIA SERA
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B: update 2009
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen seroclearance during chronic HBV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus biology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new role for an old marker, HBsAg
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen (HBsAg): a 40-year-old hepatitis B virus seromarker gets new life
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa‐2b in HBeAg‐positive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen quantification as a current-day paradox: obtaining the gold in the face of diminishing returns.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.24473
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.24473
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
PubMed publication ID
21793018
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21793018
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21793018%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
